BioSpace News Archive

Lannett Company, Inc. announced that it has entered into an exclusive U.S. commercialization agreement for a therapeutically equivalent generic of Spiriva® Handihaler® with Respirent Pharmaceuticals Co. Ltd.

T-Cypher Bio, a rapidly emerging private biotech company pioneering a novel approach to TCR-based therapeutics, announces the formation and members of its Scientific Advisory Board comprising international leaders of T cell immunology.

Calithera Biosciences, Inc., a fully-integrated clinical-stage biotechnology company focused on discovering and developing novel, small molecule drugs for the treatment of cancer and other life-threatening diseases, announced that the Company’s second quarter 2021 financial results will be released on Thursday, August 5, 2021.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, announced its financial results for the quarter ended June 30, 2021.

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a new modality of orally delivered medicines, reported financial results and business highlights for the second quarter 2021.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat genetically defined diseases, reported business highlights and financial results for the second quarter ended June 30, 2021.

Atreca, Inc., a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, announced initial data from the dose escalation portion of its ongoing Phase 1b trial evaluating ATRC-101 in select solid tumor types that displayed greater than 50% target expression in preclinical studies.

Sutro Biopharma, Inc. announced that Chief Executive Officer, Bill Newell, will participate in a panel titled “ADCs – Take Me to Your Tumor” at the 12th Annual Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 11, at 2:20 p.m. ET / 11:20 a.m. PT.

Baxter International Inc., a leading global medical products company, reported results for the second quarter of 2021.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced the appointment of industry veteran Helen Collins, M.D., to its board of directors.